EMG
ASPX

Ellington Management Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Ellington Management Group’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,300
Closed -$226K – 951
2014
Q4 		$226K Buy
+4,300
New +$126K 0.08% 412

Other funds holding ASPX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ellington Management Group's ASPX Position: Q1 2015 in Review

Ellington Management Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q1 2015, closing a stake of 4,300 shares — an estimated $226K sold.

Ellington Management Group first reported a position in ASPX in Q4 2014 and held it in 1 quarter. The position peaked at $226K in Q4 2014. 138 funds tracked by Wall St. Rank hold ASPX as of Q1 2015.

  • Ellington Management Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Ellington Management Group sold 4,300 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $226K.
  • Ellington Management Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • Ellington Management Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $226K in Q4 2014.
  • 138 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Ellington Management Group's 13F filing for Q1 2015, filed 15 May 2015.